The Cardiovascular Research Foundation^® (CRF^®) is pleased to announce that Symbiosis has won the TCT^® 2024 Shark Tank Innovation Competition for its development of an adjustable transcatheter mitral valve replacement (TMVR) system. The competition took place during Transcatheter Cardiovascular Therapeutics^® (TCT^®), the annual scientific symposium of CRF^® and the world’s premier educational meeting specializing in interventional cardiovascular medicine, October 27-30 in Washington, DC. The winner was also presented with the Jon DeHaan Foundation Award for Innovation in Cardiology.

Pregnant women with obesity face an increased risk of complications, including the need for a cesarean section, which carries its own set of risks. A University of Oklahoma physician-researcher recently earned a $3.1 million National Institutes of Health grant to lead a multicenter national clinical trial studying whether antibiotics given at the beginning of labor induction result in a decrease in C-sections. The trial is thought to be the first large-scale study of its kind in the United States.

The World Health Organization System for Reporting Pancreaticobiliary Cytopathology introduces a seven-tier category system to standardize terminology and nomenclature. This system includes the following categories: Insufficient/non-diagnostic, benign/negative for malignancy, atypia, pancreaticobiliary neoplasm low-risk/grade, pancreaticobiliary neoplasm high-risk/grade, suspicious for malignancy, and malignant categories. Adopting a standardized reporting scheme facilitates consistent diagnostic criteria among pathologists, thereby reducing report variability and enhancing communication with the clinical team for optimal patient management. The report also highlights the role of critical ancillary tests in improving diagnostic accuracy for pancreatic lesions and discusses practical approaches to managing solid and cystic pancreatic lesions.